Related Experiment Video
Updated: Jun 18, 2025

06:56
Isolation of Double Negative αβ T Cells from the Kidney
Published on: May 16, 2014
12.3K
C/EBPδ Mediates Immunity to Renal Autoinflammatory Disorders in a Stage-specific Manner
Ipsita Dey1, Yang Li1, Tiffany C Taylor1
1University of Pittsburgh, Division of Rheumatology and Clinical Immunology, Pittsburgh, PA.
Journal of Immunology (Baltimore, Md. : 1950)
|July 31, 2024
Summary
CCAAT/enhancer-binding protein (C/EBP) δ is elevated in kidney disease and essential for its progression. However, C/EBPδ and IL-17 signaling have divergent roles in kidney fibrosis, suggesting stage-specific functions in disease pathogenesis.
Area of Science:
- Immunology
- Nephrology
- Molecular Biology
Background:
- Kidney disease poses a significant health and economic burden, necessitating novel therapeutic strategies.
- Th17 cells and IL-17 signaling are implicated in autoantibody-induced glomerulonephritis (AGN) pathogenesis.
- Downstream IL-17 signaling pathways in autoimmunity remain incompletely understood.
Purpose of the Study:
- To investigate the role of CCAAT/enhancer-binding protein (C/EBP) δ in the pathogenesis of kidney disease.
- To elucidate the downstream signaling pathways of IL-17 in autoimmune kidney disease.
- To determine the specific contributions of C/EBPδ and IL-17 to renal fibrotic events.
Main Methods:
- Analysis of kidney biopsies from human AGN patients and a mouse model of anti-glomerular basement membrane disease.
- Utilizing Cebpd knockout mice to assess disease susceptibility and pathology.
- Employing a nephrotoxic injury model with aristolochic acid I to evaluate fibrotic responses.
Main Results:
- C/EBPδ was elevated in human AGN kidney biopsies and a mouse model, with Cebpd deficiency conferring complete protection.
- C/EBPδ was required in the radioresistant compartment for GN pathology and induced kidney injury markers like Il6 and Lcn2.
- Contrary to expectations, deficiency in C/EBPδ or IL-17 receptor enhanced kidney fibrosis in a separate injury model.
Conclusions:
- C/EBPδ is a critical mediator in the pathogenesis of autoimmune kidney disease.
- IL-17 and C/EBPδ exhibit divergent, stage-specific roles in kidney disease progression and fibrosis.
- These findings highlight a complex interplay between IL-17 signaling and C/EBPδ in renal pathology.
Related Concept Videos
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
Cell Specific Gene Expression
13.5K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.5K
Autoimmune Disorders
404
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
404
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K

